Skip to main content

Table 2 Total symptom scores over Days 2 to 4 (TSS2-4), ANCOVA-adjusted means, FAS

From: Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

   

I-C vs. placebo

 

N

Adjusteda mean (SE)

Adjusteda mean (SE) differenceb

95 % CI

p-value*

TSS0 c

     

 I-C

98

6.75 (0.17)

   

 Placebo

97

6.79 (0.18)

   

TSS2-4

     

 I-C

98

5.78 (0.25)

−0.61 (0.36)

(-1.32, 0.10)

0.0895

 Placebo

97

6.39 (0.25)

   
  1. CI confidence interval, SE standard error
  2. *For ANCOVA-adjusted comparison of placebo with I-C
  3. aThe means were adjusted for TSS0
  4. bA negative treatment difference favored I-C
  5. cTSS0 values are unadjusted means
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us